Tavexia Lifecare Limited (BOM:539519)
India · Delayed Price · Currency is INR 1.200
+0.010 (0.84%)
At close: Oct 7, 2026
Tavexia Lifecare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 460 | 280 | 209 | 271 | 195 | 71 | |
Market Cap Growth | 41.18% | 33.81% | -22.70% | 39.01% | 175.88% | -9.03% |
Enterprise Value | 484 | 299 | 212 | 272 | 189 | 68 |
Last Close Price | 1.20 | 0.73 | 0.91 | 1.18 | 1.08 | 1.16 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | 132.28 | 8.41 | 22.74 | 35.19 | 352.96 |
PS Ratio | 1.45 | 0.87 | 3.98 | 7.62 | 8.80 | 4.55 |
PB Ratio | 1.06 | 0.64 | 0.87 | 1.22 | 1.26 | 1.90 |
P/TBV Ratio | 1.06 | 0.65 | 0.87 | 1.22 | 1.26 | 1.90 |
P/OCF Ratio | - | - | 192.00 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.53 | 0.93 | 4.02 | 7.66 | 8.52 | 4.39 |
EV/EBITDA Ratio | - | - | 6.51 | 14.13 | 18.60 | 61.84 |
EV/EBIT Ratio | - | - | 7.48 | 17.65 | 23.83 | 135.90 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.08 | 0.08 | 0.02 | 0.01 | 0.02 | 0.03 |
Debt / EBITDA Ratio | - | - | 0.16 | 0.09 | 0.23 | 0.91 |
Net Debt / Equity Ratio | 0.05 | 0.05 | 0.02 | 0.01 | 0.01 | 0.01 |
Net Debt / EBITDA Ratio | -0.34 | -0.41 | 0.15 | 0.07 | 0.16 | 0.36 |
Net Debt / FCF Ratio | - | -0.12 | -1.29 | -0.05 | -0.05 | -0.04 |
Asset Turnover | - | 0.47 | 0.21 | 0.18 | 0.21 | 0.36 |
Inventory Turnover | - | 5.25 | 0.20 | 0.41 | 0.19 | 0.79 |
Quick Ratio | - | 0.19 | 2.49 | 4.63 | 4.03 | 2.69 |
Current Ratio | - | 1.39 | 6.43 | 10.33 | 8.02 | 5.77 |
Return on Equity (ROE) | - | 0.63% | 10.79% | 6.32% | 5.77% | 0.54% |
Return on Assets (ROA) | - | -5.15% | 7.09% | 4.86% | 4.75% | 0.72% |
Return on Invested Capital (ROIC) | -14.80% | -16.21% | 9.46% | 6.31% | 5.93% | 0.92% |
Return on Capital Employed (ROCE) | - | -12.90% | 11.60% | 6.90% | 5.10% | 1.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -1.38% | 0.76% | 11.90% | 4.40% | 2.84% | 0.28% |
FCF Yield | -38.08% | -62.60% | -1.78% | -10.23% | -15.66% | -16.15% |
Buyback Yield / Dilution | -15.55% | -99.74% | 0.18% | -49.84% | -150.78% | - |